Autoantibodies to factor VIII

Autoimmunity Reviews

Volumn 1, Issue 1-2, 2002, Pages 105-110

  Lacroix Desmazes, Sébastien ^a   Misra, Namita ^a   Bayry, Jagadeesh ^a   Mohanty, Dipika ^a   Kaveri, Srini V ^a   Kazatchkine, Michel D ^a  

^a NONE

Author keywords

Autoantibody; Factor VIII; Idiotype; Natural antibodies

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 8 INHIBITOR; CROSS REACTING ANTIBODY; CROSS REACTING ANTIGEN; ANTIIDIOTYPIC ANTIBODY;

ANTIBODY AFFINITY; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTICOAGULATION; ANTIGEN BINDING; AUTOIMMUNITY; B LYMPHOCYTE; CELL MATURATION; CROSS REACTION; DISEASE ASSOCIATION; EPITOPE MAPPING; HUMAN; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; LYMPHOCYTE CLONE; MUTATION; NONHUMAN; PROTEIN LOCALIZATION; REVIEW; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; B-LYMPHOCYTES; FACTOR VIII; HUMANS; MODELS, IMMUNOLOGICAL;

EID: 0141991802     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(01)00017-9     Document Type: Review

References (37)

1. Hultin M.B. Acquired inhibitors in malignant and nonmalignant diseases states. Am J Med. 91:1991;9S-13S.
2. Kasper C.K., Aledort L.M., Counts R.B. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh. 34:1975;869-872.
3. Kessler C.M. An introduction to FVIII inhibitors: the detection and quantitation. Am J Med. 91:1991;1S-5S.
4. Verbruggen B., Novakova I., Wessels H., Boezeman J., van den Berg M., Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for Factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost. 73:1995;247-251.
5. Haugie C. Coagulation inhibitors. Ogston D., Bennet J. Hemostasis: Biochemistry, physiology and pathology. 1977;477-490 John Wiley, London.
6. McMillan C.W., Shapiro S.S., Whitehurst D., Hoyer L.W., Rao A.V., Lazerson J. The natural history of factor VIII:C inhibitors in patients with Hemophilia A: a national cooperative study. II Observations on the initial development of factor VIII:C inhibitors. Blood. 71:1988;344.
7. Gilles J.G.G., Lavend'homme R., Jacquemin M.G., Peerlinck K., Vermylen J., Saint-Remy J.M.R. Anti-factor VIII antibodies belonging to the IgA1 isotype in a mild hemophilia A patient. Lee C.A., Kessler C.M. XXIII International Congress. 4:1998;234 Blackwell Science, The Hague, The Netherlands.
8. Shapiro S. The immunologic character of acquired inhibitors of antihemophiliac globulin (Factor VIII) and the kinetics of their interaction with FVIII. J Clin Invest. 46:1967;147-156.
9. Lacroix-Desmazes S, Moreau A, Sooryanarayana, Bonnemain C, Stieltjes N, Pashov A, Sultan Y, et al. Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat Med 1999;5:1044-7.
10. Coutinho A., Kazatchkine M.D., Avrameas S. Natural autoantibodies. Curr Opin Immunol. 7:1995;812-818.
11. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol. Today. 12:1991;154-159.
12. Dighiero G., Lymberi P., Mazie J.-C., Rouyre S., Butler-Browne G.S., Avrameas S. Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol. 131:1983;2267-2272.
13. Dighiero G., Poncet P., Rouyre S., Mazie J. Newborn Xid mice carry the genetic information for the production of natural autoantibodies against DNA, cytoskeletal proteins, and TNP. J Immunol. 136:(11):1986;4000-4005.
14. Prabhakar B.S., Saegusa J., Onodera T., Notkins A.L. Lymphocytes capable of making monoclonal antibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol. 133:1984;2815-2817.
15. Elson C.J., Naysmith J.D., Taylor R.B. B-cell tolerance and autoimmunity. Int Rev Exp Pathol. 19:1979;137-203.
16. Rossi F., Guilbert B., Tonnelle C., Ternynck T., Fumoux F., Avrameas S., et al. Idiotypic interactions between normal human polyspecific IgG and natural IgM antibodies. Eur J Immunol. 20:1990;2089-2094.
17. Algiman M., Dietrich G., Nydegger U., Boieldieu D., Sultan Y., Kazatchkine M.D. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc Natl Acad Sci USA. 89:1992;3795-3799.
18. Dietrich G., Kaveri S.V., Kazatchkine M.D. A V region-connected autoreactive subfraction of normal human serum immunoglobulin G. Eur J Immunol. 22:1992;1701-1706.
19. Kasper C., Aledort L., Counts R. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh. 34:1975;869-872.
20. Gilles J.G., Saint-Remy J.M. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies. J Clin Invest. 94:1994;1496-1505.
21. Moreau A., Lacroix-Desmazes S., Stieltjes N., Saenko E., Kaveri S.V., d'Oiron R., et al. Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity, are present in the plasma of non-responder patients with severe hemophilia A and healthy blood donors. Blood. 95:2000;3435-3441.
22. Dietrich G., Piechaczyk M., Pau B., Kazatchkine M.D. Evidence for a restricted idiotypic and epitopic specificity of anti-thyroglobulin autoantibodies in patients with autoimmune thyroiditis. Eur J Immunol. 21:1991;811-814.
23. Dietrich G., Kazatchkine M.D. Human natural self-reactive antibodies. Coutinho A., Kazatchkine M.D. Autoimmunity: Physiology and Disease. 1994;107-128 Wiley-Liss, New York.
24. Sultan Y., Rossi F., Kazatchkine M.D. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies. Proc Natl Acad Sci USA. 84:1987;828-831.
25. Ayouba A., Ferreira C., Coutinho A. Distinguishable patterns of connectivity in serum immunoglobulins from SLE patients and healthy individuals. Scand J Immunol. 45:1997;408-416.
26. Dwyer D.S., Bradley R.J., Urquhart C.K., Kearney J.F. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature. 301:1983;611-614.
27. Kazatchkine M.D. Mechanisms of action of intravenous immunoglobulins (IVIg) therapy in autoimmune and inflammatory disorders. Publ P. Immunoglobulins: extending the horizons. 1994;1-12. London.
28. Ronda N., Haury M., Nobrega A., Coutinho A., Kazatchkine M.D. Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg). Clin Immunol Immunopathol. 70:1994;124-128.
29. Ronda N., Haury M., Nobrega A., Kaveri S.V., Coutinho A., Kazatchkine M.D. Analysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int Immunol. 6:1994;1651-1660.
30. Ruiz-Arguelles A. Spontaneous reversal of acquired autoimmune dysfibrinogenemia probably due to an anti-idiotypic antibody directed to an interspecies cross-reactive idiotype expressed on anti-fibrinogen antibodies. J Clin Invest. 82:1988;958-963.
31. van Doorn P.A., Rossi F., Brand A., van Lint M., Vermeulen M., Kazatchkine M.D. On the mechanism of high dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 29:1990;57-64.
32. van Doorn P.A., Brand A., Strengers P.F.W., Meulstee J., Vermeulen M. High dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double blind placebo controlled, cross-over study. Neurology. 40:1990;209-212.
33. Zouali M., Eyquem A. Idiotypic/antiidiotypic interactions in systemic lupus erythematosus: demonstration of oscillary levels of anti-DNA autoantibodies and reciprocal antiidiotypic activity in a single patient. Ann Inst Pasteur Immunol. 134C:1983;377-391.
34. Zouali M., Eyquem A. Expression of anti-idiotypic clones against auto-anti-DNA antibodies in normal individuals. Cell Immunol. 76:1983;137-147.
35. Dietrich G., Algiman M., Sultan Y., Nydegger U.E., Kazatchkine M.D. Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg). Blood. 79:1992;2946-2951.
36. Sultan Y., Kazatchkine M.D., Maisonneuve P., Nydegger U.E. Anti-idiotypic suppression of autoantibodies to Factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. 2:1984;765-768.
37. Rossi F., Sultan Y., Kazatchkine M.D. Anti-idiotypes against autoantibodies and alloantibodies to Factor VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins. Clin Exp Immunol. 74:1988;311-316.